In vitro cytotoxicity of montelukast in HAPI and SH-SY5Y cells.
Sign Up to like & getrecommendations! Published in 2020 at "Chemico-biological interactions"
DOI: 10.1016/j.cbi.2020.109134
Abstract: Montelukast is a cysteinyl leukotriene (CysLT) receptor antagonist with efficacy against a variety of diseases, including asthma and inflammation-related conditions. However, various neuropsychiatric events (NEs) suspected to be related to montelukast have been reported recently,… read more here.
Keywords: hapi sy5y; hapi cells; montelukast; hapi ... See more keywords
Risk of readmissions, mortality, and hospital‐acquired conditions across hospital‐acquired pressure injury (HAPI) stages in a US National Hospital Discharge database
Sign Up to like & getrecommendations! Published in 2020 at "International Wound Journal"
DOI: 10.1111/iwj.13482
Abstract: Pressure injuries are one of the most common and costly complications occurring in US hospitals. With up to 3 million patients affected each year, hospital‐acquired pressure injuries (HAPIs) place a substantial burden on the US… read more here.
Keywords: acquired pressure; risk; hospital; pressure injuries ... See more keywords
An Integrated System of Braden Scale and Random Forest Using Real-Time Diagnoses to Predict When Hospital-Acquired Pressure Injuries (Bedsores) Occur
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Environmental Research and Public Health"
DOI: 10.3390/ijerph20064911
Abstract: Background and Objectives: Bedsores/Pressure Injuries (PIs) are the second most common diagnosis in healthcare system billing records in the United States and account for 60,000 deaths annually. Hospital-Acquired Pressure Injuries (HAPIs) are one classification of… read more here.
Keywords: system; time; braden scale; hapi ... See more keywords